New Pathway for Chemical Modification of Sialic Acid Uncovered at Hannover Medical School
Recent research at the Hannover Medical School (MHH) has revealed how acetyl components from inside cells reach the surface, significantly influencing immune responses. Understanding this mechanism is crucial as it may open new avenues for treating diseases characterized by immune system dysfunction.
The Role of Sialic Acid in Cellular Communication
Sialic acid plays a critical role in the molecular recognition patterns that facilitate communication between trillions of body cells. These sugar chains on cell surfaces serve as key identifiers that the immune system uses to distinguish self from non-self. An altered sialic acid pattern can influence the immune system’s recognition of its own cells, potentially leading to autoimmune reactions or allowing tumor cells, which often exhibit increased sialic acid, to evade immune detection. One common modification is known as O-acetylation, where specific components are exchanged at one or two locations on the sialic acid molecule.
Discovering the Pathway to Chemical Modification
A research team led by PD Dr. Martina Mühlenhoff, a scientist at MHH’s Institute of Clinical Biochemistry, has made significant strides in understanding how these acetyl components are transported to their target locations. Their findings validate a suspected pathway and unveil a previously unknown mechanism. The significance of this research extends beyond basic science; certain viruses utilize O-acetylated sialic acids as receptors to enter host cells, and various tumors show increased O-acetylation levels of sialic acids.
Mechanisms of O-Acetylation
The O-acetylation process occurs in the Golgi apparatus, the cell’s central “post and distribution hub.” This modification can be likened to a chemical Lego set, where individual pieces can be swapped and reassembled. A hydrogen atom at one or two oxygen atoms in the sialic acid is replaced with a larger acetyl group, resulting in an overall increase in size and a permanent change in the properties of sialic acid.
Research indicated that the acetyl components arrive at the Golgi apparatus via a transporter protein called SLC33A1. The research team has confirmed this pathway for the first time, demonstrating that genetic changes in SLC33A1, often found in children with the Huppke-Brendel syndrome, impair the O-acetylation process, leading to severe neurological and developmental issues from infancy.
Two Distinct Transport Pathways
The protein CASD1 accelerates the sugar modification process, acting as a catalyst in the Golgi apparatus. Researchers identified a second catalytic center within CASD1, explaining how it can attach acetyl groups at different positions on the sialic acid. This newly discovered catalytic center forms a portal for the transport of acetyl groups through the Golgi membrane.
Implications for Viral Infections
These findings are not just crucial for fundamental research but have profound implications for understanding how viruses exploit the chemical state of sialic acid as an entry point into cells. For instance, Influenza C viruses, which primarily cause respiratory diseases in young children, depend on O-acetylated sialic acids to invade host cells. Conversely, Influenza A and B can only enter cells if the sialic acid remains unchanged. Specific coronaviruses also recognize O-acetylated sialic acids as molecular keys that activate their spike proteins, facilitating infection.
Sialic acids may represent a promising target for developing better strategies to combat viral infections in the future. Dr. Mühlenhoff emphasizes the potential of understanding these processes to enhance our ability to fight viral diseases effectively.
Conclusion
The research conducted at Hannover Medical School not only sheds light on the intricate workings of cellular biochemistry but also emphasizes the broader implications for immunology and virology. The discoveries made could pave the way for future therapeutic interventions targeting cellular communication mechanisms, offering hope for more effective treatments of autoimmune diseases and viral infections alike.
Service Announcement: For more detailed information, refer to the original publication titled “Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis” available here.
